Source:http://linkedlifedata.com/resource/pubmed/id/11786969
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-1-11
|
pubmed:abstractText |
Patients with Budd-Chiari syndrome (BCS) may require treatment with portal decompressive surgery or liver transplantation. Transjugular intrahepatic portosystemic shunt (TIPS) represents a new treatment alternative, but its long-term effect on BCS outcome has not been evaluated. Twenty-one patients with BCS consecutively admitted to our unit were evaluated. The mean follow-up was 4 +/- 3 years. Seven patients had nonprogressive forms and were successfully controlled with medical therapy; 1 case, with a short-length hepatic vein stenosis was successfully treated by angioplasty. All 8 patients are alive and asymptomatic. The remaining 13 patients, had a TIPS because of clinical deterioration (in one of them, because early TIPS thrombosis a successful side-to-side portacaval shunt [SSPCS] was performed) followed by an improvement in clinical condition. However, a patient with fulminant liver failure before TIPS insertion, died 4 months later and another patient with cirrhosis at diagnosis had liver transplantation 2 years later. The remaining 11 patients are alive and free of ascites. In 3 of these patients TIPS is patent after 3, 6, and 12 months. The remaining 8 patients developed late TIPS dysfunction. In two of these cases, after angioplasty and restenting, TIPS is patent after a follow-up of 9 and 80 months. In 5 other patients, recurring TIPS occlusion was not further corrected because no signs of portal hypertension were present. In conclusion, in patients with BCS uncontrolled with medical therapy, TIPS is a highly effective technique that is associated with long-term survival.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0270-9139
|
pubmed:author |
pubmed-author:BoschJaumeJ,
pubmed-author:CervantesFranciscoF,
pubmed-author:EscorsellAngelsA,
pubmed-author:García-PagánJuan CarlosJC,
pubmed-author:GilabertRosaR,
pubmed-author:MoitinhoEduardoE,
pubmed-author:PerellóAntoniaA,
pubmed-author:ReverterJuan CarlosJC,
pubmed-author:RodésJuanJ,
pubmed-author:SuárezYanetteY
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
132-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11786969-Abdominal Pain,
pubmed-meshheading:11786969-Adolescent,
pubmed-meshheading:11786969-Adult,
pubmed-meshheading:11786969-Aged,
pubmed-meshheading:11786969-Biopsy,
pubmed-meshheading:11786969-Budd-Chiari Syndrome,
pubmed-meshheading:11786969-Female,
pubmed-meshheading:11786969-Hepatic Veins,
pubmed-meshheading:11786969-Humans,
pubmed-meshheading:11786969-Liver,
pubmed-meshheading:11786969-Male,
pubmed-meshheading:11786969-Middle Aged,
pubmed-meshheading:11786969-Portasystemic Shunt, Transjugular Intrahepatic,
pubmed-meshheading:11786969-Survival Rate,
pubmed-meshheading:11786969-Treatment Outcome,
pubmed-meshheading:11786969-gamma-Glutamyltransferase
|
pubmed:year |
2002
|
pubmed:articleTitle |
TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.
|
pubmed:affiliation |
Hepatic Hemodynamic Laboratory, Liver Unit, Institut de Malalties Digestives, University of Barcelona, Barcelona, Catalunya, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|